Close

JPMorgan Assumes BridgeBio Pharma (BBIO) at Overweight

February 22, 2021 1:55 AM EST Send to a Friend
JPMorgan analyst Anupam Rama assumes coverage on BridgeBio Pharma (NASDAQ: BBIO) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login